Fatal brain infection caused by Aspergillus glaucus in an immunocompetent patient identified by sequencing of the ribosomal 18S-28S internal transcribed spacer

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 10, 2007, Pages 747-750

  Traboulsi, R S ^a   Kattar, M M ^a   Dbouni, O ^a   Araj, G F ^a   Kanj, S S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; TUBERCULOSTATIC AGENT; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLUS; ASPIRATION PNEUMONIA; BRAIN ABSCESS; BRAIN BIOPSY; BRAIN INFECTION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; LABORATORY TEST; MALE; PRIORITY JOURNAL; RIBOSOME; SEROLOGY; TELEOMORPH;

ADULT; ASPERGILLUS; BRAIN DISEASES; DNA, RIBOSOMAL SPACER; FATAL OUTCOME; HUMANS; IMMUNOCOMPETENCE; MALE; NEUROASPERGILLOSIS; RNA, RIBOSOMAL, 18S; RNA, RIBOSOMAL, 28S;

EID: 34548481767     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0361-x     Document Type: Article

References (22)

1. Paterson DL (2004) New clinical presentations of invasive aspergillosis in non-conventional hosts. Clin Microbiol Infect 10(Suppl 1):24-30
2. Salaki JS, Lourira DB, Chmel H (1984) Fungal and yeast infections of the central nervous system: a clinical review. Medicine (Baltimore) 63(2):108-132
3. Ashdown BC, Tien RD, Felsberg GJ (1994) Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. AJR Am J Roentgenol 162(1):155-159
4. Walsh TJ, Hier DB, Caplan LR (1985) Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 18(5):574-582
5. Siddiqui AA, Shah AA, Bashir SH (2004) Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: clinical spectrum and outcome in 25 cases. Neurosurgery 55(3):602-611
6. Kim DG, Hong SC, Kim HJ, Chi JG, Han MH, Choi KS, Han DH (1993) Cerebral aspergillosis in immunologically competent patients. Surg Neurol 40(4):326-331
7. Alrajhi AA, Enani M, Mahasin Z, Al-Omran K (2001) Chronic invasive aspergillosis of the paranasal sinuses in immunocompetent hosts from Saudi Arabia. Am J Trop Med Hyg 65(1):83-86
8. Szymanska J (2005) Evaluation of mycological contamination of dental unit waterlines. Ann Agric Environ Med 12(1):153-155
9. Curtis L, Cali S, Conroy L, Baker K, Ou CH, Hershow R, Norlock-Cruz F, Scheff P (2005) Aspergillus surveillance project at a large tertiary-care hospital. J Hosp Infect 59(3):188-196
10. Sridhar H, Jayshree RS, Bapsy PP, Appaji L, Navin Kumar M, Shafiulla M, VijayKumar BR (2002) Invasive aspergillosis in cancer. Mycoses 45(9-10):358-363
11. Yoshida K, Ando M, Ito K, Sakata T, Arima K, Araki S, Uchida K (1990) Hypersensitivity pneumonitis of a mushroom worker due to Aspergillus glaucus. Arch Environ Health 45(4):245-247
12. Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, Lafe K, Bui U, Limaye AP, Cookson BT (2001) Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol 39(11):4042-4051
13. Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, LaFe K, Yarfitz SL, Limaye AP, Cookson BT (2000) Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J Clin Microbiol 38(6):2302-2310
14. Rakeman JL, Bui U, LaFé K, Chen YC, Honeycutt RJ, Cookson BT (2005) Multilocus DNA sequence comparisons rapidly identify pathogenic molds. J Clin Microbiol 43(7):3324-3333
15. Sutton DA, Fothergill AW, Rinaldi MG (1998) Guide to clinically significant fungi. Williams and Wilkins, Baltimore, p 54
16. St-Germain G, Summerbell R (1996) Identifying filamentous fungi. Star Publishing, Belmont, CA, p 68
17. Hussain S, Salahuddin N, Ahmad I, Salahuddin I, Jooma R (1995) Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals. Eur J Radiol 20(2):151-155
18. Lin SJ, Schrannz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32(3):358-366
19. Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347(6):408-415
20. Patterson TF, Kirkpatrick WR, White M et al (2000) Invasive aspergillosis. Disease, spectrum, treatment practices, and outcomes. 13 Aspergillus Study Group. Medicine (Baltimore) 79(4):250-260
21. Araujo R, Pina-Vaz C, Rodrigues AG (2007) Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. Int J Antimicrob Agents 29(1):108-111
22. Black KE, Baden LR (2007) Fungal infections of the CNS: treatment strategies for the immunocompromised patient. CNS Drugs 21(4):293-318